In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.
dc.contributor.author | Roblin, P M | |
dc.contributor.author | Hammerschlag, M R | |
dc.date.accessioned | 2023-06-30T16:46:27Z | |
dc.date.available | 2023-06-30T16:46:27Z | |
dc.date.issued | 1998-04 | |
dc.identifier.citation | Roblin PM, Hammerschlag MR. In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. Antimicrob Agents Chemother. 1998 Apr;42(4):951-2. doi: 10.1128/AAC.42.4.951. PMID: 9559818; PMCID: PMC105577. | en_US |
dc.identifier.issn | 0066-4804 | |
dc.identifier.pmid | 9559818 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12648/10345 | |
dc.description.abstract | The in vitro susceptibilities of 10 strains of Chlamydia pneumoniae to a new 8-methoxyquinolone, BAY 12-8039, and to ofloxacin, doxycycline, and erythromycin were determined. The activity of BAY 12-8039 was similar to that of ofloxacin, with a MIC at which 90% of the isolates had no inclusions and a minimal chlamydicidal concentration at which 90% of the isolates had no inclusions after passage of 1.0 microg/ml, but this activity was less than those of doxycycline and erythromycin. | |
dc.language.iso | en | en_US |
dc.relation.url | https://journals.asm.org/doi/epub/10.1128/aac.42.4.951 | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae. | en_US |
dc.type | Article/Review | en_US |
dc.source.journaltitle | Antimicrobial agents and chemotherapy | en_US |
dc.source.volume | 42 | |
dc.source.issue | 4 | |
dc.source.beginpage | 951 | |
dc.source.endpage | 2 | |
dc.source.country | United States | |
dc.description.version | VoR | en_US |
refterms.dateFOA | 2023-06-30T16:46:28Z | |
html.description.abstract | The in vitro susceptibilities of 10 strains of Chlamydia pneumoniae to a new 8-methoxyquinolone, BAY 12-8039, and to ofloxacin, doxycycline, and erythromycin were determined. The activity of BAY 12-8039 was similar to that of ofloxacin, with a MIC at which 90% of the isolates had no inclusions and a minimal chlamydicidal concentration at which 90% of the isolates had no inclusions after passage of 1.0 microg/ml, but this activity was less than those of doxycycline and erythromycin. | |
dc.description.institution | SUNY Downstate | en_US |
dc.description.department | Pediatrics | en_US |
dc.description.degreelevel | N/A | en_US |
dc.identifier.journal | Antimicrobial agents and chemotherapy | |
dc.identifier.issue | 4 | en_US |